Human Immunodeficiency Virus Type 1 (HIV-1)
Also known as: Human Immunodeficiency Virus - Type 1 / HIV-I / HIV-1 / Human Immunodeficiency Virus Type 1 / Immunodeficiency Virus Type 1, Human / Human Immunodeficiency Virus-1 / Human Immunodeficiency Virus-1 (HIV-1) / Human Immunodeficiency Virus-Type 1 / Human Immunodeficiency Virus 1 / Human T-cell leukemia virus III / T-lymphotropic virus / Human T-cell leukaemia virus III / T-lymphotropic virus (organism) / Human immunodeficiency virus type 1 [Ambiguous] / Human immunodeficiency virus type I (organism) / Human immunodeficiency virus type I -RETIRED- / [X]Human immunodeficiency virus disease (disorder) / Human immunodeficiency virus [HIV] disease / [X]Unspecified human immunodeficiency virus [HIV] disease (disorder) / HIV disease / (AIDS) or (HIV infection) / HTLV-III/LAV infection -RETIRED- / HIV infection NOS / Human immunodeficiency virus syndrome / Human immunodeficiency virus infection, unspecified / HIV Infections / HIV infection / Human immunodeficiency virus infection (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB11751 | Cabotegravir | An HIV-1 integrase inhibitor. |
DB12301 | Doravirine | A non-nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals to treat HIV-1 infections. |
DB00879 | Emtricitabine | A nucleoside reverse transcriptase inhibitor used for the treatment and prophylaxis of HIV. |
DB00109 | Enfuvirtide | An HIV-1 gp41 fusion inhibitor used in patients experiencing HIV-1 replication who are already being treated with other anti-retrovirals. |
DB09299 | Tenofovir alafenamide | A nucleoside analog reverse transcriptase inhibitor used for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease. |